GSK PLC (GSK)
36.97
+0.09
(+0.24%)
USD |
NYSE |
Nov 04, 16:00
36.98
+0.01
(+0.03%)
After-Hours: 20:00
GSK Debt to Equity Ratio: 1.146 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.146 |
| June 30, 2024 | 1.179 |
| March 31, 2024 | 1.284 |
| December 31, 2023 | 1.260 |
| September 30, 2023 | 1.586 |
| June 30, 2023 | 1.692 |
| March 31, 2023 | 1.769 |
| December 31, 2022 | 1.885 |
| September 30, 2022 | 2.416 |
| June 30, 2022 | 1.350 |
| March 31, 2022 | 2.060 |
| December 31, 2021 | 1.538 |
| September 30, 2021 | 1.660 |
| June 30, 2021 | 1.657 |
| March 31, 2021 | 1.764 |
| December 31, 2020 | 1.785 |
| September 30, 2020 | 1.977 |
| June 30, 2020 | 2.331 |
| March 31, 2020 | 2.444 |
| December 31, 2019 | 2.565 |
| September 30, 2019 | 2.807 |
| June 30, 2019 | 9.258 |
| March 31, 2019 | 7.912 |
| December 31, 2018 | 6.875 |
| September 30, 2018 | 6.191 |
| Date | Value |
|---|---|
| June 30, 2018 | 7.628 |
| March 31, 2018 | -253.00 |
| December 31, 2017 | -250.34 |
| September 30, 2017 | 14.71 |
| June 30, 2017 | 23.27 |
| March 31, 2017 | 10.70 |
| December 31, 2016 | 16.66 |
| September 30, 2016 | 140.30 |
| June 30, 2016 | 34.12 |
| March 31, 2016 | 6.048 |
| December 31, 2015 | 3.239 |
| September 30, 2015 | 3.044 |
| June 30, 2015 | 2.517 |
| March 31, 2015 | 2.483 |
| December 31, 2014 | 4.386 |
| September 30, 2014 | 3.760 |
| June 30, 2014 | 2.885 |
| March 31, 2014 | 2.606 |
| December 31, 2013 | 2.596 |
| September 30, 2013 | 3.081 |
| June 30, 2013 | 2.906 |
| March 31, 2013 | 2.886 |
| December 31, 2012 | 3.142 |
| September 30, 2012 | 2.810 |
| June 30, 2012 | 2.443 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.146
Minimum
Sep 2024
2.565
Maximum
Dec 2019
1.768
Average
1.728
Median
Debt to Equity Ratio Benchmarks
| AstraZeneca PLC | 0.8173 |
| Pfizer Inc | 0.7831 |
| Adaptimmune Therapeutics PLC | 0.2592 |
| TC BioPharm (Holdings) PLC | -- |
| Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 77.68B |
| Total Liabilities (Quarterly) | 59.68B |
| Shareholders Equity (Quarterly) | 18.75B |
| Current Ratio | 0.8061 |
| Net Debt Paydown Yield | 1.34% |